Bravera Wealth’s Qiagen QGEN Stock Holding History

Bravera Wealth’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-129	Closed	-$5.8K	–	481
2025 Q4	$5.8K	Buy	+129	New	+$5.97K	﹤0.01%	337

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bravera Wealth's QGEN Position: Q1 2026 in Review

Bravera Wealth sold out of Qiagen (QGEN) in Q1 2026, closing a stake of 129 shares — an estimated $5.8K sold.

Bravera Wealth first reported a position in QGEN in Q4 2025 and held it in 1 quarter. The position peaked at $5.8K in Q4 2025. 344 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

Bravera Wealth reported no remaining Qiagen position as of Q1 2026 after selling out during the quarter.
Bravera Wealth sold 129 Qiagen shares in Q1 2026, an estimated $5.8K.
Bravera Wealth first reported a position in Qiagen in Q4 2025 and held it in 1 quarter.
Bravera Wealth's Qiagen position peaked at $5.8K in Q4 2025.
344 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Bravera Wealth's 13F filing for Q1 2026, filed 22 Apr 2026.